| Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
|---|
| 07/28/2005 | WO2005068411A1 Process for the preparation of 6-fluoro-2-methyl-1-indanone |
| 07/28/2005 | US20050165240 Chemical intermediates for production of sibutramine |
| 07/28/2005 | US20050165114 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents; AP-1 activation inhibitor, NF-kappa B activation inhibitor |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165069 Statine derivatives for the treatment of Alzheimer's disease |
| 07/28/2005 | US20050164225 Bis-diazo,triaryl and aryldiazo-N-arylphenazonium moieties; labels for polynucleotides, nucleosides, nucleotides, and polypeptides; fluorescence resonance energy transfer |
| 07/27/2005 | EP1557408A1 Recording material comprising diphenyl sulfone derivative and novel diphenyl sulfone derivative compound |
| 07/27/2005 | EP1556342A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 07/27/2005 | EP1556029A2 Thiomolybdate analogues and uses thereof |
| 07/27/2005 | CN1646488A Substituted aryl ketones |
| 07/27/2005 | CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles |
| 07/27/2005 | CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them |
| 07/26/2005 | US6921823 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
| 07/26/2005 | US6921777 E.g., ethyl 3-methyl-5-(,5,8,8-tetra-methyl-5,6,7,8-tetra-hydronaphthalen-2 -ylselenyl)pent-2-en-4-ynoate; dermatological, rheumatic, respiratory, cardiovascular and ophthalmological uses as well as cosmetic uses |
| 07/26/2005 | CA2234642C 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 07/21/2005 | WO2005066119A2 Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols and preparation thereof |
| 07/21/2005 | WO2005042478A3 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 07/21/2005 | US20050159611 Process for producing shogaols and intermediates for the synthesis thereof |
| 07/21/2005 | US20050159459 inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful to reduce forming beta peptides |
| 07/21/2005 | US20050159314 Converting substituted mono or bicyclic lactones in presence of an amine base and a catalytic amount of a cyanide or alkali or alkaline metal alcoholate, to a salt, reacting the salt with carbonyl compound containing an organic substituent |
| 07/21/2005 | DE4218614B4 Benzolderivate Benzene derivatives |
| 07/20/2005 | EP1555313A2 Method for the identification of hydroxyphenylpyruvate dioxygenase inhibitors |
| 07/20/2005 | EP1268396B1 Diphenyl ether compounds useful in therapy |
| 07/20/2005 | EP1066237B1 Processes for preparing intermediates |
| 07/20/2005 | CN1642992A Photoinitiator and photocurable composition of novel compound |
| 07/20/2005 | CN1642908A Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative |
| 07/20/2005 | CN1211359C New phenalkyoxy-phenyl derivatives |
| 07/19/2005 | US6919380 Carbocyclic esters such as 5-chloro-2-methanesulfonylindan-1--yl-4-chlorobenzoate, used as anorexigenic agents; dietetics |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/14/2005 | WO2005063729A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 07/14/2005 | WO2005063703A1 Process for producing 2-halogenobenzamide compound |
| 07/14/2005 | WO2005063665A1 Propofol analogs, process for their preparation, and methods of use |
| 07/14/2005 | WO2005063018A1 Haloalkene compounds, process for their production and pesticides containing them |
| 07/14/2005 | WO2005023198A3 Modafinil compositions |
| 07/14/2005 | US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance |
| 07/14/2005 | US20050154063 Process for the preparation of modafinil |
| 07/14/2005 | US20050154056 Inhibitors of HCV NS5B polymerase |
| 07/14/2005 | US20050153996 Compounds that modulate ppar activity and methods for their preparation |
| 07/14/2005 | US20050153958 Substituted aryl ketones |
| 07/14/2005 | US20050153244 Sulfonate derivatives and the use thereof as latent acids |
| 07/14/2005 | CA2551610A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 07/14/2005 | CA2551567A1 Propofol analogs, process for their preparation, and methods of use |
| 07/13/2005 | EP1553078A1 Calcium receptor-active compounds |
| 07/13/2005 | EP1551799A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 07/13/2005 | EP1551798A1 Novel sulphones for inhibition of gamma secretase |
| 07/13/2005 | EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 07/13/2005 | EP1242424B1 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 07/13/2005 | CN1639116A Phenolic compound and recording material containing the same |
| 07/13/2005 | CN1639115A Semicarbazide derivatives and their use as antithrombotics |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636457A Fungicides for the control of take-all disease of plants |
| 07/13/2005 | CN1210270C Novel use of phenylheteroalkylamine derivatives |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210257C Substituted aromatic-ring compounds, process for producing the same, and and use thereof |
| 07/13/2005 | CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds |
| 07/12/2005 | US6916938 Method for preparing sulfone or sulfoxide compound |
| 07/12/2005 | US6916837 Such as 2-(6-amidino-2-naphthyloxy)-5-methanesulfonyl-aminobenzoic acid trifluoroacetate; blood coaggulation factor VII inhibitors |
| 07/12/2005 | US6916835 Nitrate esters and their use for neurological conditions |
| 07/07/2005 | WO2005060692A2 Biphenyl compounds and methods |
| 07/07/2005 | WO2004098516A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 07/07/2005 | US20050148798 Synthesis of vinylsulfones |
| 07/07/2005 | US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment |
| 07/06/2005 | EP1549710A1 Graftable 4-amino-3-sulfinyl-substituted diphenylamine stabilizers for vulcanizates |
| 07/06/2005 | EP1549613A1 Sulfonamides having antiangiogenic and anticancer activity |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 07/06/2005 | CN1636298A Graft oligomeric electrolytes |
| 07/06/2005 | CN1635994A Process for preparation of carotenoids |
| 07/06/2005 | CN1209336C Process for preparation of 2-halobenzoic acids |
| 07/05/2005 | US6914159 Which have excellent therapeutic effects against hypertension, congestive heart failure, angina pectoris or prostatic hypertrophy higher yield; isolation step i.e. chromatography is not needed |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 06/30/2005 | WO2005058269A1 Merocyanine derivatives for cosmetic use |
| 06/30/2005 | US20050143457 Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | DE10355223A1 Neue Makrocyclen zur Behandlung von Krebserkrankungen New macrocycles for the treatment of cancer |
| 06/29/2005 | EP1548003A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 06/29/2005 | EP1546093A1 Process for making bicalutamide and intermediates thereof |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 06/29/2005 | EP1546086A2 Aminoalcohol derivatives |
| 06/29/2005 | CN1633411A Compounds for modulating cell proliferation |
| 06/29/2005 | CN1208316C Process and intermediate compound for preparing retinol |
| 06/29/2005 | CN1208314C Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use |
| 06/23/2005 | WO2005057714A1 Electrolyte solution for secondary battery and secondary battery using same |
| 06/23/2005 | WO2005056519A1 Alpha-ketoamide derivative, and production method and use thereof |
| 06/23/2005 | WO2005056518A1 Sulfur- or oxygen-containing oxime ether compounds with biocidal activity |
| 06/23/2005 | WO2005056510A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/23/2005 | WO2004046094A9 Histone deacetylase inhibitors |
| 06/23/2005 | US20050137263 e.g., 2-[(4-Ethyl-2-fluorophenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)benzamide, is administered to treat arthritis |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137191 Nitrate esters and their use for mitigating cellular damage |
| 06/23/2005 | CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |